期刊文献+

正五聚蛋白3在炎症及自身免疫中的作用 被引量:14

Role of pentraxin 3 in inflammation and autoimmunity
下载PDF
导出
摘要 正五聚蛋白3(pentraxin 3,PTX3)属正五聚蛋白家族成员,又称肿瘤坏死因子刺激基因14(tumornecrosis factor-stimulated gene 14,TSG14),是一种典型的急性期蛋白。PTX3作为唯一的可溶性模式识别受体,可以结合多种可溶性受体配体,参与免疫防御、炎症、细胞凋亡、血管重塑。 As a soluble pattern-recognition receptor, pentraxin 3 (PTX3) evolves in various physiological and pathological effects on inflammation, autoimmunity, apoptosis, vessel remodeling, female fertility and vascular endothelial injury. PTX3 is also a sensitive biological marker for detecting severity and activity of various autoimmune diseases. In most cases, PTX3 limits the progress of autoimmunity and plays a protective role in the process of autoimmune diseases.
作者 谢京 张静波
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第4期752-756,共5页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30971366) 重庆市国际合作项目(No.CSTC201110004) 第三军医大学临床科研基金资助项目(No.2011XLC37)
关键词 急性期蛋白 正五聚蛋白3 天然免疫 炎症 自身免疫 Acute-phase reactive proteins Pentraxin 3 Innate immunity Inflammation Autoimmunity
  • 相关文献

参考文献3

二级参考文献35

  • 1Stephen J. Nicholls, MBBS, PhD,E. Murat Tuzcu, MD,IIke Sipahi, MD,Adam W. Grasso, MD,Paul Schoenhagen, MD,Tingfei Hu, MS,Kathy Wolski, MPH,Tim Crowe, BS,Milind Y. Desai, MD,Stanley L. Hazen, MD, PhD,Samir R. Kapadia, MD,Steven E. Nissen, MD,李呈亿(译).他汀、高密度脂蛋白胆固醇与冠状动脉粥样硬化消退[J].美国医学会杂志(中文版),2007,26(3):152-160. 被引量:48
  • 2Appel LJ,Frohlich ED,Hall JE,et al.The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke:a call to action from the American Heart Association[J].Circulation,2011,123(10):1138-1143.
  • 3Sniderman AD,Williams K,Contois JH,et al.A meta-analysis of low-density lipoprotein cholesterol,non-high-density lipoprotein cholesterol,and apolipoprotein B as markers of cardiovascular risk[J].Circ Cardiovasc Qual Outcomes,2011,4(3):337-345.
  • 4Expert pannel on Detection,Evaluation and Treatment of High Blood cholesterol in Adults.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)[J].JAMA,2001,285(19):2486-2497.
  • 5Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S)[J].Lancet,1994,344(8934):1383-1389.
  • 6Blaustein MP,Zhang J,Chen L,et al.How does salt retention raise blood pressure?[J].Am J Physiol Regul Integr Comp Physiol,2006,290(3):R514-R523.
  • 7Liu Z.Dietary sodium and the incidence of hypertension in the Chinese population:a review of nationwide surveys[J].Am J Hypertens,2009,22(9):929-933.
  • 8Ferrario CM,Smith R,Levy P,et al.The hypertension-lipid connection:insights into the relation between angiotensin II and cholesterol in atherogenesis[J].Am J Med Sci,2002,323(1):17-24.
  • 9Rosendorff C,Black HR,Cannon CP,et al.Treatment of hypertension in the prevention and management of ischemic heart disease:a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention[J].Circulation,2007,115(21):2761-2788.
  • 10Tsimikas S,Brilakis ES,Miller ER,et al.Oxidized phospholipids,Lp(a) lipoprotein,and coronary artery disease[J].N Engl J Med,2005,353(1):46-57.

共引文献40

同被引文献153

  • 1杨世伟,王大为,秦玉明,李军,王凤鸣,左维嵩.基质金属蛋白酶-9在川崎病外周血表达及其在冠状动脉损伤中的临床意义[J].南京医科大学学报(自然科学版),2005,25(2):87-90. 被引量:5
  • 2王宏伟.川崎病并发心血管损害的若干问题[J].中国实用儿科杂志,2006,21(10):730-732. 被引量:47
  • 3Kallenberg CG, Stegeman CA, Heeringa P. Autoantibodies vex the vasculature[J]. Nat Med, 2008, ld(10): 1018-1019.
  • 4Kallenberg CG. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go? [J]. Clin Exp Immunol, 2011, 164(Suppl 1): 1-3.
  • 5Kalsch AI, Csemok E, Munch D, et al. Use of highly sensitive C-reactive protein for followup of Wegener's granulomatosis[J]. J Rheumatol, 2010, 37(11): 2319-2325.
  • 6Fazzini F, Peri G, Doni A, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation[J]. Arthritis Rheum, 2001, 44(12): 2841-2850.
  • 7Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11.
  • 8Heller I, Isakov A, Topilsky M. American college of rheumatology criteria for the diagnosis of vasculitis[J]. Ann Intern Med, 1999, 130(10): 861-862.
  • 9Levey AS, Coresh J, Greene T, et al. Expressing themodification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values[J]. Clin Chem, 2007, 53(4): 766-772.
  • 10Muso E, Endo T, Itabashi M, et al. Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts [J]. Clin Exp Nephrol, 2013, 17(5): 659-662.

引证文献14

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部